BIOTECHNOLOGY VALUE FUND L P - 20 Nov 2025 SCHEDULE 13D/A Report for Repare Therapeutics Inc. Common Shares, no par value (RPTX)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
Repare Therapeutics Inc. Common Shares, no par value
Symbol
RPTX
Shares outstanding
43,056,667 shares
Disclosed Ownership
10,333,600 shares
Ownership
24%
Form type
SCHEDULE 13D/A
Filing time
24 Nov 2025, 17:05:05 UTC
Date of event
20 Nov 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 12% 5,309,432 0 5,309,432 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0000918923
BVF I GP LLC 12% 5,309,432 0 5,309,432 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803805
BIOTECHNOLOGY VALUE FUND II LP 10% 4,308,573 0 4,308,573 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001102444
BVF II GP LLC 10% 4,308,573 0 4,308,573 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803806
Biotechnology Value Trading Fund OS LP 1.3% 548,938 0 548,938 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001660683
BVF Partners OS Ltd. 1.3% 548,938 0 548,938 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001660684
BVF GP HOLDINGS LLC 22% 9,618,005 0 9,618,005 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803809
BVF PARTNERS L P/IL 24% 10,333,600 0 10,333,600 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001055947
BVF INC/IL 24% 10,333,600 0 10,333,600 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001056807
LAMPERT MARK N 24% 10,333,600 0 10,333,600 /s/ Mark N. Lampert Mark N. Lampert 0001233840